Health2 years ago
New Alzheimer’s drug: why the not-yet-approved donanemab aroused excitement
Within a year, a second drug was found to be effective for: To check for cognitive decline in patients with early Alzheimer’s disease. Donanemab, developed by...
Recent Comments